AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Murray International Trust PLC

Board/Management Information Apr 13, 2021

4594_rns_2021-04-13_3bc7b6dc-5d98-4107-8e73-36bca754a76d.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2823V

Murray International Trust PLC

13 April 2021

MURRAY INTERNATIONAL TRUST PLC (the "Company")

Legal Entity Identifier (LEI):  549300BP77JO5Y8LM553

13 April 2021

Appointment of New Director

The Board of Murray International Trust PLC is pleased to announce the appointment of Mr Nicholas Melhuish as an independent non-executive Director of the Company with effect from 1 May 2021. 

Dr Kevin Carter, Chairman, commented on the appointment:

"I am delighted to announce that Mr Nicholas Melhuish will be joining the Board from 1 May 2021.

Nick brings a wealth of valuable global investment expertise to the Board having joined Corpus Christi College, Oxford as Fellow and Bursar in 2018 following a portfolio management career most recently as Head of Global Equities at Amundi SA.  He is a non executive director of JPMorgan Claverhouse Investment Trust PLC, a trustee of the Trusthouse Charitable Foundation and a director and trustee of The London Clinic."

There are no disclosures required to be made for Mr Melhuish, in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

Mr Melhuish holds 1,724 Ordinary shares in the Company.

Aberdeen Asset Management PLC

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAGIGDSUGBDGBX

Talk to a Data Expert

Have a question? We'll get back to you promptly.